{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:10:45Z","timestamp":1782436245503,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.yexmp.2023.104860","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T10:53:54Z","timestamp":1681469634000},"page":"104860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder"],"prefix":"10.1016","volume":"131","author":[{"given":"Paul Giacomo","family":"Bruch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Plage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Kornienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Ro\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Schallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Lennartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niclas C.","family":"Blessin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Samtleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Slojewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystian","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Ecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Hallmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Adamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Schlomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sefer","family":"Elezkurtaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2023.104860_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/modpathol.3880300","article-title":"Comparison of the WHO\/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World\/health organization\/Internattional Society of Urologic Pathology","volume":"14","author":"Alsheikh","year":"2001","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00428-018-2354-9","article-title":"Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications","volume":"472","author":"Barth","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.yexmp.2023.104860_bb0015","doi-asserted-by":"crossref","first-page":"21186","DOI":"10.1038\/s41598-021-00628-5","article-title":"Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5\/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer","volume":"11","author":"Bejrananda","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2023.104860_bb0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/path.893","article-title":"Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies","volume":"195","author":"Bubendorf","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.urolonc.2009.04.019","article-title":"Molecular pathways of urothelial development and bladder tumorigenesis","volume":"28","author":"Castillo-Martin","year":"2010","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0035","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Consortium, G","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2023.104860_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","article-title":"Meta-analysis of the luminal and basal subtypes of bladder Cancer and the identification of signature Immunohistochemical markers for clinical use","volume":"12","author":"Dadhania","year":"2016","journal-title":"EBioMedicine."},{"key":"10.1016\/j.yexmp.2023.104860_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133256","article-title":"Intratumoral switch of molecular phenotype and overall survival in muscle invasive bladder cancer","volume":"14","author":"De Carlo","year":"2022","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.yexmp.2023.104860_bb0050","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.urolonc.2011.07.017","article-title":"When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression","volume":"31","author":"DeGraff","year":"2013","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0055","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/modpathol.3880241","article-title":"Relationship of cytokeratin 20 and CD44 protein expression with WHO\/ISUP grade in pTa and pT1 papillary urothelial neoplasia","volume":"13","author":"Desai","year":"2000","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104762","article-title":"Cytokeratin 7 and cytokeratin 20 expression in cancer: a tissue microarray study on 15,424 cancers","volume":"126","author":"Dum","year":"2022","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/embr.201338254","article-title":"Dedifferentiation and reprogramming: origins of cancer stem cells","volume":"15","author":"Friedmann-Morvinski","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.yexmp.2023.104860_bb0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1078-1439(02)00271-5","article-title":"Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder","volume":"21","author":"Gee","year":"2003","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.critrevonc.2017.03.010","article-title":"Recent advances in genitourinary tumors: a review focused on biology and systemic treatment","volume":"113","author":"Gonz\u00e1lez Del Alba","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0080","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1038\/s41598-020-66747-7","article-title":"Assessment of luminal and basal phenotypes in bladder Cancer","volume":"10","author":"Guo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2023.104860_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00428-021-03145-y","article-title":"Association of current molecular subtypes in urothelial carcinoma with patterns of muscularis propria invasion","volume":"479","author":"Haghayeghi","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.yexmp.2023.104860_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2559.1995.tb00025.x","article-title":"Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease","volume":"27","author":"Harnden","year":"1995","journal-title":"Histopathology."},{"key":"10.1016\/j.yexmp.2023.104860_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2019.08.001","article-title":"Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5\/6, 14 and 20","volume":"43","author":"Jangir","year":"2019","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/his.13763","article-title":"Immunohistochemistry of cytokeratin (CK) 5\/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma","volume":"74","author":"Jung","year":"2019","journal-title":"Histopathology."},{"key":"10.1016\/j.yexmp.2023.104860_bb0105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder Cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2169","article-title":"A single-cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yexmp.2023.104860_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2023.104860_bb0120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexmp.2023.104860_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13059-014-0560-6","article-title":"Gateways to the FANTOM5 promoter level mammalian expression atlas","volume":"16","author":"Lizio","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0130","doi-asserted-by":"crossref","first-page":"D737","DOI":"10.1093\/nar\/gkw995","article-title":"Update of the FANTOM web resource: high resolution transcriptome of diverse cell types in mammals","volume":"45","author":"Lizio","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexmp.2023.104860_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAI.0000000000000872","article-title":"Urothelial carcinoma in situ of the bladder: correlation of CK20 expression with adaptive immune resistance, response to BCG therapy, and clinical outcome","volume":"29","author":"Lombardo","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jjco\/hyaa219","article-title":"Impact of immunohistochemistry-based molecular subtype on predicting chemotherapy response and survival in patients with T1 stage bladder cancer after bladder-preserving treatment","volume":"51","author":"Lu","year":"2021","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0145","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000478-200108000-00013","article-title":"Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens","volume":"25","author":"McKenney","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1083\/jcb.111.2.567","article-title":"Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns","volume":"111","author":"Moll","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0155","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.1111\/jcmm.16712","article-title":"Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in ta non-muscle-invasive bladder cancer","volume":"25","author":"Muilwijk","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.yexmp.2023.104860_bb0160","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.humpath.2012.08.011","article-title":"Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases","volume":"44","author":"Oliva","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200301000-00001","article-title":"Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas","volume":"27","author":"Parker","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2022.09.004","article-title":"GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder","volume":"130","author":"Plage","year":"2022","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0175","first-page":"431","article-title":"Immunohistochemical characterization of urothelial carcinoma","volume":"114","author":"Rajcani","year":"2013","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.yexmp.2023.104860_bb0180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder Ccancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell."},{"key":"10.1016\/j.yexmp.2023.104860_bb0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00428-019-02618-5","article-title":"Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder","volume":"475","author":"Rodriguez Pena","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.yexmp.2023.104860_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.04.005","article-title":"Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review","volume":"215","author":"Sanguedolce","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexmp.2023.104860_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095154","article-title":"Profiling the biological characteristics and transitions through upper tract tumor origin, bladder recurrence, and muscle-invasive bladder progression in upper tract urothelial carcinoma","volume":"23","author":"Shigeta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2023.104860_bb0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00428-008-0585-x","article-title":"Diagnostic algorithm for papillary urothelial tumors in the urinary bladder","volume":"452","author":"Shim","year":"2008","journal-title":"Virchows Arch."},{"key":"10.1016\/j.yexmp.2023.104860_bb0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/path.4886","article-title":"Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification","volume":"242","author":"Sj\u00f6dahl","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexmp.2023.104860_bb0210","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2023.104860_bb0215","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nmeth.3995","article-title":"A proposal for validation of antibodies","volume":"13","author":"Uhlen","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.yexmp.2023.104860_bb0220","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/cyt.12463","article-title":"Cytokeratin 20 immunocytochemistry on urine sediments: a potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma","volume":"28","author":"Wadhwa","year":"2017","journal-title":"Cytopathology."},{"key":"10.1016\/j.yexmp.2023.104860_bb0225","first-page":"2677","article-title":"Clinical use of tumor markers for the detection and prognosis of bladder carcinoma: a comparison of CD44, cytokeratin 20 and Survivin","volume":"13","author":"Yikilmaz","year":"2016","journal-title":"Urol. J."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480023000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480023000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:17:07Z","timestamp":1757992627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480023000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":45,"alternative-id":["S0014480023000114"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2023.104860","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2023.104860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104860"}}